Plaque Analysis Now Covered for 84% of Florida Patients, including Florida Blue.

Preventive Action for a Progressive Threat.

Heartflow Plaque Analysis delivers a comprehensive, AI-driven assessment of coronary artery disease. By quantifying total plaque volume and composition, including high-risk non-calcified plaque, it enables you to deliver more personalized preventive care for every patient.

total plaque volume img 1
admin ajax

The Largest Prospective Registry on Plaque Analysis in Coronary Artery Disease1

The DECIDE Registry is a landmark prospective study of nearly 22,000 patients at over 30 centers across the United States.

Over 50% of Patients

had medical management changed after Plaque Analysis.

~1/3 of Patients

with CAC 0 had a change in management.

~15% Expected Decrease in Risk of Cardiac Event

based on avg LDL-C decrease of 18.7 mg/dL.2

Majority of Lives in Florida Now Have Access to Plaque Analysis.

Plaque Analysis is covered by major insurers in the state:
  • Medicare3
  • Florida Blue
  • Aetna
  • UnitedHealthcare
  • Cigna

Medical Necessity Guidelines

Plaque Analysis is considered reasonable and medically necessary as a diagnostic study when:
  1. The patient is eligible for CCTA, and;
  2. The patient presents with acute or stable chest pain and is at intermediate risk for CAD or has evidence of CAD-RADS level 1, 2, or 3 disease (>0 and <70 stenosis) on their CCTA and;
  3. The patient is negative or inconclusive for acute coronary syndrome (ACS)
group 3 1024x987

Transform Plaque Insights into Decisive Action

With coverage in place for your patients, it’s time to leverage Plaque Analysis to deliver more personalized preventive care. Connect with your Heartflow representative to find out how to order this test.
Hear From Your Peers
screenshot 2025 11 05 at 9.27.52 am 1 1

“Today, what we know is cardiovascular disease mortality is actually increasing over the past decade despite all the advances in pharmaceutical agents as well as cardiac imaging. Quantitative plaque actually is a way to individualize a patient’s regimen based upon their own disease.”

Dr. Rinehart,
MD, FACC, FSCCT

Plaque Staging*: How Insights Transform Into Action

Demonstrated by the DECIDE Registry, Plaque Staging* is the most clinically validated tool for informing actionable treatment plans based on total plaque volume (TPV), simplifying decision-making and personalizing preventive treatment based on patient risk.1,4
Learn More
plaque staging